FDA Inspection 1063219 — Siegfried St. Vulbas SAS
The FDA completed an inspection of Siegfried St. Vulbas SAS on June 29, 2018 in Saint-Vulbas. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 29, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Saint-Vulbas (France)